# KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

> **NCT05483491** · PHASE1 · RECRUITING · sponsor: **Christian Hinrichs** · enrollment: 30 (estimated)

## Conditions studied

- Gastric Cancer
- Breast Cancer
- Cervical Cancer
- Lung Cancer

## Interventions

- **BIOLOGICAL:** KK-LC-1 TCR-T cells
- **DRUG:** Aldesleukin

## Key facts

- **NCT ID:** NCT05483491
- **Lead sponsor:** Christian Hinrichs
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-26
- **Primary completion:** 2026-09-01
- **Final completion:** 2028-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-03-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05483491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05483491, "KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer". Retrieved via MORVS 2026-10-16 from https://api.morvs.ai/clinical/NCT05483491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*